APA Alıntı

Tarhini, A. A., Leng, S., Moschos, S. J., Yin, Y., Sander, C., Lin, Y., . . . Kirkwood, J. M. (2012). Safety and immunogenicity of vaccination with MART-1 (26-35, 27L), gp100 (209-217, 210M), and tyrosinase (368-376, 370D) in-adjuvant with PF-3512676 and GM-CSF in metastatic melanoma.

Chicago Stili Alıntı

Tarhini, Ahmad A., Siyang Leng, Stergios J. Moschos, Yan Yin, Cindy Sander, Yan Lin, William E. Gooding, ve John M. Kirkwood. Safety and Immunogenicity of Vaccination With MART-1 (26-35, 27L), Gp100 (209-217, 210M), and Tyrosinase (368-376, 370D) In-adjuvant With PF-3512676 and GM-CSF in Metastatic Melanoma. 2012.

MLA Alıntı

Tarhini, Ahmad A., et al. Safety and Immunogenicity of Vaccination With MART-1 (26-35, 27L), Gp100 (209-217, 210M), and Tyrosinase (368-376, 370D) In-adjuvant With PF-3512676 and GM-CSF in Metastatic Melanoma. 2012.